Prostate cancer is a type of cancer that occurs in the prostate, a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm. It is one of the most common types of cancer in men. Prostate cancer usually grows slowly and initially remains confined to the prostate gland, where it may not cause serious harm. However, while some types of prostate cancer grow slowly and may need minimal or even no treatment, other types are aggressive and can spread quickly.

African nations, particularly those in Sub-Saharan Africa, are significantly affected by prostate cancer for several reasons:

Higher Incidence and Mortality Rates: Studies have shown that African men have a higher risk of developing prostate cancer than men of other racial and ethnic groups. Additionally, they are more likely to be diagnosed at a later stage, and the cancer tends to be more aggressive, leading to higher mortality rates.

Genetic Factors: There may be genetic factors that predispose African men to a higher risk of prostate cancer. Research is ongoing to understand these genetic links better.

Access to Healthcare: Limited access to healthcare services, including screening and early detection programs, contributes to the higher mortality rates. Many African countries have under-resourced healthcare systems, which makes it challenging to implement widespread screening programs.

Awareness and Stigma: There may be lower awareness about prostate cancer and its symptoms in some African communities. Additionally, cultural stigma surrounding cancer and discussing health issues related to the reproductive system can prevent men from seeking help early.

Diet and Lifestyle Factors: Some studies suggest that diet and lifestyle factors may contribute to the risk of developing prostate cancer. However, more research is needed to understand these links better.

Addressing prostate cancer in African nations requires a multi-faceted approach, including improving access to healthcare, increasing awareness and education about the disease, and investing in research to understand the unique risk factors and develop effective treatments for African populations.

Prostate Cancer no Longer Casts a Shadow Over the Vibrant Future of Africa.

In the fight against prostate cancer in African nations, a beacon of hope shines brightly through the multifaceted approach being adopted. The Marine Foundation, with its unwavering commitment to health and well-being, has introduced the Health Development and Distribution Agency (HDA) as a cornerstone for change. This groundbreaking platform is set to revolutionize healthcare access across the continent, ensuring that the recently discovered solution, proven to be 100% effective for all African populations, reaches every corner, every village, and every individual in need. Together, with improved healthcare access and heightened awareness, we stand on the brink of a new era where prostate cancer no longer casts a shadow over the vibrant future of Africa.

Prostate 3000 Years of Maya Tradition and the Discovery by Efraín CONTRERAS since 1960
(Following World Health Organization (WHO) guidelines:

THE POWER OF ODYLIRESIN™

Iresine Celosia: A Legacy of Healing from the Mayas 3000 Years ago, to the Modern World.

Ancient Roots: Iresine celosia, a Central American plant, has been revered for its therapeutic properties since the Maya-Quiche civilization, dating back 3000 years.

Pioneering Discovery: In 1960, Efraín Contreras, a descendant of a distinguished family with a legacy in literature and health, unveiled the medicinal virtues of Iresine celosia in Nicaragua, earning a patent for his groundbreaking work. Mr. Efrain Contreras was an eminant naturopathe

Family Tradition: The Contreras family, including Efraín’s grandson René Rosenberg Contreras and his wife Odylie Escobar, played pivotal roles in advancing the research and global introduction of Iresine celosia, culminating in the creation of ODYLIRESIN™ ANTIOXIDANT.

Global Impact: Edda Contreras, continuing the family’s mission, has been instrumental in promoting Iresine celosia worldwide, aligning with the World Health Organization’s support for herbal medicine.

A Modern Marvel: Today, Iresine International, Inc. stands at the forefront, offering ODYLIRESIN™ ANTIOXIDANT as a testament to the enduring power of nature’s remedies and the visionary efforts of the Contreras family.

ODYLIRESIN™ is a special formula made from a plant called Iresine celosia. This plant belongs to a group of plants that includes things like beets and spinach. It’s been known for a long time, even mentioned way back in 1552 in an important book about medicinal plants from the Americas.

From 2011 to 2022, a scientist named Dr. C.G. Killian and others, under the guidance of Professor Navindra P. Seeram from the University of Rhode Island, found two new substances in this plant that nobody knew about before. They named these substances Celosiadines A and B and wrote about them in a scientific journal, which means they’re officially recognized in the scientific community.

ODYLIRESIN™ is pretty special because it has been shown to work really well for men’s health, particularly for problems with the prostate, which is a gland in men that can sometimes cause issues. Unlike other treatments, they say ODYLIRESIN™ is very successful, doesn’t pose any risks, and doesn’t have bad side effects.

Dr. Daniele Porru, a urologist from the University of Pavia, tested ODYLIRESIN™ in a small study with men who had benign prostatic hyperplasia (BPH), which is when the prostate is larger than normal but not cancerous. The study showed that the formula with Celosiadines A and B was powerful in helping with prostate problems. These findings were also published in a medical journal.

The use of Iresine celosia for health purposes in Europe started with René James Rosenberg Contreras in 1988, who was the grandson of Efraín Contreras, a well-known therapist from Nicaragua. Efraín Contreras discovered in 1960 that Iresine celosia could help with abnormal cell growth, which can sometimes lead to cancer. In Nicaragua, doctors at two hospitals did some studies on this in the 1980s and earlier, and it seems they found some promising results too.

ODYLIRESIN™ is a product made from a specific plant, Iresine celosia, which is proved to be effective in treating prostate disorders and incredibly benign prostatic hyperplasia (BPH). BPH is a condition where the prostate gland in men enlarges, which can cause problems with urination and bladder control.

The main benefits of ODYLIRESIN™ are:

High Success Frequency: It has a high effectiveness rate in treating prostate issues without any reported side effects.

Safety: The product is claimed to have no risks or side effects, especially concerning the male libido, which means it doesn’t negatively affect sexual function.

Novelty: It contains newly discovered substances, Celosiadines A and B, which seem to have a potent effect on the prostate and could be a new approach to treating prostate disorders.

Historical Use: The plant’s use for medicinal purposes has a long history, suggesting that it has been valued for its therapeutic properties for many years.

The studies mentioned suggest that the product has been rigorously tested and shown to have a powerful action on the prostate, making it an essential discovery for men’s health, particularly for those dealing with prostate problems.

Regarding regions where prostate health is a significant concern, prostate disorders including BPH and prostate cancer are prevalent in many parts of the world, but certain factors can influence their incidence in specific regions:

Western Countries: These countries report higher rates of prostate cancer, which could be due to better screening procedures, a higher life expectancy, and potentially lifestyle and genetic factors.

African Countries: Some African countries have reported higher mortality rates from prostate cancer, potentially due to less access to screening and treatment options.

Developed vs. Developing Nations: Developed countries often have more resources for the diagnosis and treatment of prostate conditions, including BPH and prostate cancer, leading to higher reported incidence but better survival rates. In contrast, developing nations may have lower reported rates due to underdiagnosis but could also have higher mortality rates due to less access to treatment.

Diet and Lifestyle Factors: Regions where diets are high in fat and low in vegetables might see higher rates of prostate problems.

Genetics: Some ethnicities have a higher risk of prostate issues, like men of African descent.

For ODYLIRESIN™, the regions that would benefit the most are those with high rates of BPH and where traditional or alternative medicine is part of the healthcare approach. It serves as an alternative treatment where conventional medical resources are scarce or in populations that prefer herbal or plant-based remedies. It is beneficial in regions where the medical community is open to integrating new and alternative treatments into standard care practices.

Imagine if there were a treatment that could significantly help with prostate cancer, particularly for populations at higher risk, such as men of African descent, it could potentially have a profound impact on the health sector in Africa.

Here’s how such a treatment could be beneficial in an African context:

Improved Health Outcomes: With a high success rate, the treatment could dramatically reduce the mortality rate from prostate cancer in African countries, improving the overall life expectancy and quality of life for men in these regions.

Reduced Healthcare Costs: Effective treatments could lower long-term healthcare costs by reducing the need for expensive surgeries, medications, and long-term care.

Enhanced Access to Care: If the treatment is affordable and does not require complex medical infrastructure, it would be more accessible to men in remote or under-resourced areas.

Community Impact: As men often play a crucial role in the socio-economic fabric of African societies, improving men’s health can have positive ripple effects on families and communities.

Cultural Acceptance: If the treatment aligns with local cultural practices and preferences for herbal and natural medicines, it could see higher rates of acceptance and compliance.

Educational Opportunities: The introduction of such a treatment could be accompanied by educational programs about prostate health, further benefiting the population.

Research and Development: Local production and research into such treatments could spur scientific development and create jobs within African countries.

Preventive Care: With a treatment known to be highly effective, there could be more emphasis on preventive screenings, leading to earlier detection and treatment of prostate issues.

In the spirit of collaboration and a shared vision for a healthier future, we extend a heartfelt invitation to the Medical & Health Communities and the Honorable Ministries of Health across Africa to join us in a continental initiative dedicated to advancing healthcare and wellbeing for all. Our collective expertise, insights, and stewardship are vital in shaping health strategies, enhancing disease prevention, and ensuring accessible and equitable healthcare delivery. We stand at the cusp of transformative progress, and your participation is crucial in driving this change. Please join our HDA Forum for Health Distribution & Development as we convene to discuss, deliberate, and design the path forward in our fight against the health challenges of our time. Together, we can forge a legacy of health and vitality for present and future generations.

The Marine Foundation had a product that could effectively treat prostate cancer and is ready to distribute it across Africa, leveraging its diplomatic ties and medical network, making this a groundbreaking initiative. Here’s a scenario describing how the Marine Foundation will facilitate this life-saving mission:

Strategic Distribution Plan:

1 – The Foundation would use its diplomatic connections to work closely with each country’s health ministry to gain fast-track approvals for the product.

2 – The product would be delivered efficiently to all corners of the continent through the Foundation’s established networks, ensuring even the most remote areas are reached.

Incorporation into Local Healthcare Systems:

1 – Training would be provided to local healthcare professionals on how to use and administer the treatment, ensuring a high level of competency across all regions.

2 – The Foundation would integrate the product into the existing health care protocols, making it a standard part of prostate health management in Africa.

Awareness and Education Campaigns:

1 – Launch comprehensive awareness campaigns across media platforms to educate men about prostate cancer, the importance of early detection, and the availability of the new treatment.

2 – Hold community outreach programs in local languages, making sure that cultural norms and values are respected and integrated into the communication strategy.

Affordable Access:

1 – Subsidize the cost of the product or provide it for free to ensure that no individual is denied access due to financial constraints.

2 – Establish a sustainable funding model, perhaps through a mix of donor support, government funding, and public-private partnerships, to ensure the longevity of the program.

Monitoring and Evaluation:

1 – Implement a robust system to monitor the treatment’s impact, gathering data to assess effectiveness, identify any issues, and facilitate continuous improvement.

2 – Share success stories and data with the global health community to establish best practices and encourage further investment.

Research and Continuous Improvement:

1 – Collaborate with research institutions to study the long-term effects of the treatment and develop any necessary improvements.

2 – Use feedback from the field to refine the product and its distribution methods continuously.

Building Infrastructure:

1 – Invest in the necessary medical infrastructure to ensure that the product is stored, handled, and administered under the best conditions.

2 – Support the construction and operation of specialized treatment centers where necessary.

Cultural Competence and Support:

1 – Train healthcare providers not only in the medical aspects of the product but also in the cultural competencies required to ensure respectful and effective communication with patients.

2 – Incorporate traditional medicine practices where possible and effective, blending new treatments with traditional ones respected by the community.

Through this multi-faceted approach, the Marine Foundation will significantly improve the health outcomes of men in Africa, tackling prostate cancer with an innovative and community-focused strategy.

Envisioning a future where health in Africa is not just a matter of policy but a birthright, we stand on the precipice of a transformative era. The Marine Foundation believes in tapping into the continent’s rich heritage of natural remedies, fostering a health revolution that is accessible, effective, and aligned with the wisdom of the land.

With respect and reverence for nature’s bounty, we are witnessing a renaissance of traditional medicine, supported by modern research and an unwavering commitment to the well-being of every individual. The health solutions that nature offers are not only abundant but come with the promise of purity and sustainability. The responsibility now lies with the visionary leaders of African nations to assert their sovereignty in healthcare, choosing what is genuinely beneficial for their people over the monopolies of pharmaceutical giants.

The future of health in Africa is one of independence and enlightenment, where each nation harnesses the power of its natural resources and the knowledge of its ancestors to cultivate a landscape where healthcare is a communal treasure, not a commercial commodity. The Health Development and Distribution Agency (HDA) stands ready to dispel the shadows cast by pharmaceutical control, shining a light on the treasures of nature that await our rediscovery.

This is not just a movement; it’s a pledge to return to the roots, to trust in the earth’s healing touch, and to ensure that the people of Africa have the power to shape their health destiny. As we embrace the wonders of the natural world, we are charting a course towards a future where healthcare is defined by freedom, efficacy, and the collective inheritance of nature’s gifts.

Edda CONTRERAS – Manager, PARAPHARM SARL, Swiss Holding Company, Address: 27 Rue de Montchoisy 1207 Geneva, Switzerland e-mail: info@iresine.com

The system engineered by Executive Chairman Tomeo Motto RDG includes the establishment of the Marine Foundation Trust, in addition to the Marine Foundation’s registration in Tokyo, Japan. The Marine Foundation Trust is designed to provide funds to all signature projects and agencies of the Marine Foundation platform worldwide.

To ensure the security and longevity of the funds, the Marine Foundation Trust will have accounts established in nations where the Foundation operates. This decentralized system provides assurance that funds will be available for generations to come, supporting the Foundation’s mission of global impact and sustainability.